Mecamylamine Treatment for Alcohol Dependence: A Randomized Controlled Trial

BACKGROUND AND AIMS: The nicotinic acetylcholine receptor antagonist, mecamylamine, is a potential novel pharmacotherapy for alcohol use disorder. The aims were to compare alcohol consumption between mecamylamine and placebo and test if smoking status modified treatment effects. DESIGN: Outpatient,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Addiction
Päätekijät: Petrakis, Ismene L., Ralevski, Elizabeth, Gueorguieva, Ralitza, O’Malley, Stephanie S., Arias, Albert, Sevarino, Kevin A., Jane, Jane S., O’Brien, Erin, Krystal, John H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725262/
https://ncbi.nlm.nih.gov/pubmed/28710873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.13943
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia